Drug metabolism in liver disease
- 1 January 1989
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 40 (3), 439-474
- https://doi.org/10.1016/0163-7258(89)90088-0
Abstract
No abstract availableThis publication has 154 references indexed in Scilit:
- A dispersion model of hepatic elimination: 2. Steady-state considerations-influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activityJournal of Pharmacokinetics and Biopharmaceutics, 1986
- The Influence of Liver Dysfunction on the Pharmacokinetics of CarprofenThe Journal of Clinical Pharmacology, 1985
- Intrinsic hepatic clearance and child-turcotte classification for assessment of liver function in cirrhosisJournal of Hepatology, 1985
- Pharmacokinetics of Guanabenz in Patients with Impaired Liver FunctionJournal of Cardiovascular Pharmacology, 1984
- Drug Administration in Hepatic DiseaseNew England Journal of Medicine, 1983
- Cholestasis and hepatic drug metabolismDigestive Diseases and Sciences, 1981
- The significance of phase II (conjugation) reactions in drug disposition and toxicityLife Sciences, 1979
- Theophylline Disposition in Patients with Hepatic CirrhosisNew England Journal of Medicine, 1977
- The effect of cirrhosis on the disposition and elimination of clindamycinDigestive Diseases and Sciences, 1975
- Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometryJAMA, 1967